Clinical and Microbiologic Analysis of the Risk Factors for Mortality in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bacteremia

The prevalence of the heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype among methicillin-resistant S. aureus (MRSA) blood isolates can reach 38%. hVISA bacteremia is known to be associated with vancomycin treatment failure, including persistent bacteremia. We conducted t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Chong, Yong Pil, Park, Ki-Ho, Kim, Eun Sil, Kim, Mi-Na, Kim, Sung-Han, Lee, Sang-Oh, Choi, Sang-Ho, Jeong, Jin-Yong, Woo, Jun Hee, Kim, Yang Soo
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4432213/
https://ncbi.nlm.nih.gov/pubmed/25845875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04765-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados